| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |